Skip to Main Content

A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis (CONSONANCE)

Conditions

Diseases of the Nervous System

What is the purpose of this trial?

Brief Summary:

This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sclerosis (PMS).

  • Trial with
    Genentech, Inc.
  • Start Date
    05/18/2021
  • End Date
    09/29/2023

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/15/2021
  • Study HIC
    #2000024074